This is a Mint Premium article gifted to you Download the Mint app and read premium stories Log in to our website to save your bookmarks You are just one step away from creating your watchlist Looks like you have exceeded the limit to bookmark the image In case you can’t find any email from our side This is a subscriber only feature Subscribe Now to get daily updates on WhatsApp Please enable JS and disable any ad blocker Nick Cannon is shooting down rumors that he has halted production on his forthcoming documentary centered on the life of Dr Sebi—the controversial late Honduras-based healer and herbalist who claimed to have found the cure for AIDS and other ailments Cannon took on the task of producing the doc after the tragic death of rapper Nipsey Hussle who was working on the project when he was gunned down back in March “Oh ‘They’ wish this was the truth! Hussle’s death sparked a number of conspiracy theories including one that claimed he was killed for his involvement with the documentary on the late Dr Sebi, born Alfredo Bowman, was a healer, pathologist, and biochemist, who claimed to have the cure for diseases like diabetes, HIV, and cancer. The herbalist, who was not a licensed physician, died in 2016. Algo trading has transformed the financial markets (stocks  It's the method of executing orders using automated or pre-programmed trading instructions After recognising the risks and challenges faced by retail investors the Securities and Exchange Board of India (SEBI) has introduced a regulatory framework to ensure safer participation in algo trading these new measures aim to enhance transparency and promote accountability in the algo trading space in India we break down what these changes mean for retail traders and market participants SEBI aims to address concerns regarding market manipulation The key objectives of the latest circular are: SEBI has mandated that all algo trading providers must be empanelled with stock exchanges before brokers can onboard them This prevents unverified or sketchy service providers/companies from offering algo trading solutions to retail investors Brokers must obtain prior approval from stock exchanges for each algorithm they wish to offer to retail investors any modifications to approved algorithms also require pre-approval from the exchange This ensures that all trading strategies comply with SEBI’s guidelines Brokers are responsible for monitoring investor grievances and ensuring compliance with anti-manipulation measures To prevent unauthorised access, SEBI has banned open APIs open APIs enable traders and third-party applications to connect directly to a broker’s trading platform access will be granted only through unique vendor-client setups ensuring proper identification and traceability of algo trades Retail investors who develop their own algorithms must register with stock exchanges through their brokers if their trading activity exceeds a specified order-per-second threshold These self-developed algorithms can only be used for personal accounts including those of immediate family members Algorithms that do not disclose their underlying logic must register as Research Analysts with SEBI Each algo order must be tagged with a unique identifier (an "algo ID") provided by the exchange enhancing transparency and accountability in trading activities Stock exchanges will issue SOPs for testing This includes establishing a "kill switch" mechanism allowing exchanges to disable specific algo IDs in case of irregularities Brokers and algo providers must clearly disclose all charges related to algorithmic trading SEBI has set the following timeline for the new framework: SEBI's new regulatory measures aim to strike a balance between innovation and investor protection in algo trading By ensuring a structured and transparent framework SEBI seeks to democratise access to automated/algo trading while minimising potential risks staying informed about these regulations is crucial to navigating the evolving algo trading landscape Whether you’re developing your own trading algorithm or using broker-provided strategies understanding these compliance requirements will help you trade with confidence and security Essential digital access to quality FT journalism on any device Complete digital access to quality FT journalism with expert analysis from industry leaders Complete digital access to quality analysis and expert insights complemented with our award-winning Weekend Print edition Terms & Conditions apply Discover all the plans currently available in your country Digital access for organisations. Includes exclusive features and content. See why over a million readers pay to read the Financial Times. A need was also felt to have a “short and manageable” list From 20 auditors in 2022 to 9 in 2025 the Sebi’s latest panel has excluded big names like Ernst & Young KPMG Assurance And Consulting Services and Grant Thornton Bharat only Deloitte Touche Tohmatsu India has secured a position on the latest panel for conducting forensic audits of listed companies “The current list contains those firms who were frequently engaged by Sebi in the past three years The regulator has also looked into the firms’ track record with extra points being given to the firms who were able to complete the audit work within the time specified there was an emphasis to reduce the number of panellists to a manageable number,” said a source Some experts, however, apprehend that the pruning of the list might also be a reflection of the capabilities of top auditors who have been excluded from the panel. “The Big Four firms would have met some of the market regulator’s eligibility conditions but there may have been some shortcomings,” the source said The fees offered by the regulator for assignments is at par with the present market rates “Being on the list adds a lot of credibility to the names of these firms,” said an auditing expert FE couldn’t independently verify if firms like KPMG Grant Thornton Bharat and Ernst & Young had shown interest to be a part of the panel In an advertisement floated in November 2024 Sebi had asked for the applicants to have a minimum 10 years of experience in the field of forensic audit the applicant was required to have a minimum of 10 partners or directors out of which at least 5 partners to be actively involved in forensic audit-related work the applicant was supposed to have had experience of undertaking at least 15 forensic audits in past three years out of which a minimum of three forensic audits work to be assigned by a regulatory body or government agency or a PSU the panel is valid for the next three years and the regulator will be paying a fees of Rs 10-30 lakh per assignment depending on the number of years for which forensic audit is conducted and the size of the company for which forensic audit is conducted Moody’s downgraded India’s GDP growth forecast for 2025 to 6.3% due to global economic slowdown caused by US policy uncertainty and trade restrictions including those between India and Pakistan Moody’s expects RBI to cut rates to boost growth The US and China are also facing trade tensions Louisa Richards is a Registered Nutritionist and Nutritional Therapist She sees clients and delivers workshops with her businesses Heads Up Nutrition and Vegucate Nutrition Louisa writes about nutrition and health for news and science outlets She has a passion for plant-based diets and a functional approach to health Louisa loves cooking healthy food and encouraging people to try plant-based This individual is no longer a medical reviewer in our network The credentials and contact information reflected here may not be current Adrienne Seitz is a registered dietitian and licensed dietitian nutritionist She is a practicing dietitian and cook in Sarasota where she prepares healthy and delicious food at a country club Adrienne’s special interests are plant-based diets Jon is a writer from California and now floats somewhere on an island in the Mediterranean He thinks most issues can be solved by petting a good dog Time not spent at his desk is probably spent making art or entertaining humans or other animals Katharine has a BSc in Biological Sciences from the University of Exeter Having started her career as a scientific editor on The British Journal of Psychiatry she moved to Country Life where she spent six years as deputy chief sub-editor living in both Germany and Australia and being a full-time mum she retrained and spent several years teaching A Level Biology she then embarked on a Masters in Science Communication at Imperial College Her particular interest is the effect of nutrition on health and ensuring that nutritional claims have foundations in science Sebi diet is a controversial and strict plant-based diet Some claim it can reduce the risk of disease when people combine the diet with supplements sold on the diet website Sebi believed that mucus and acidity caused disease He held that eating certain foods and avoiding others could detoxify the body achieving an alkaline state that could reduce the risk and effects of disease Recent research suggests that plant-based diets can effectively reduce a person’s dietary acid load which may help to reduce the risk of certain health conditions further research is necessary and no official sources approve the Dr Sebi diet specifically can prevent or treat medical conditions This article examines the potential benefits and risks of the Dr was a self-proclaimed healer and herbalist He was self-educated — he was not a medical doctor and held no Ph.D These and similar assertions resulted in multiple lawsuits Sebi reportedly died in 2016 in police custody Dr. Sebi believed the Western approach to disease to be ineffective. He held that mucus and acidity — rather than bacteria and viruses A main theory behind the diet is that disease can only survive in acidic environments The diet aims to achieve an alkaline state in the body to prevent or eradicate disease The diet’s official website sells botanical remedies that it claims will detoxify the body These remedies — called African Bio-mineral Balance supplements — retail for up to $1,500 per package The site links to no research supporting its claims about health benefits Those behind the site acknowledge that they are not medical doctors and do not intend the site’s content to replace medical advice Dr. Sebi’s nutritional guide includes a number of rules There is a lack of any scientific evidence to support the Dr. Sebi diet. However, research indicates that a plant-based diet can benefit health A 2022 review of observational and clinical evidence highlights research that associates a high dietary acid load with widespread inflammation and certain health conditions The review highlights that vegetarian and vegan diets can effectively reduce a person’s dietary acid load The authors claim that a vegan diet is particularly effective and they emphasize that further research is necessary to understand the full effect of plant-based diets on a person’s dietary acid load Some health benefits of plant-based diets may include: An older study of young male participants found that they felt more full and satisfied after eating a plant-based meal containing peas and beans than a meal containing meat However, more recent research from 2023 compared the satiating capacity of plant-based meals and meals containing meat in 60 adults Participants displayed no difference in feelings of fullness The Dr. Sebi diet encourages people to eat whole foods and avoid processed foods A 2020 narrative review associates a high intake of ultra-processed foods with a range of health conditions Diets with unprocessed or minimally processed foods had more beneficial health outcomes Read more about the benefits of a plant-based diet Sebi diet is restrictive and may not include enough important nutrients which the diet’s website does not clearly acknowledge There is no current research that supports the safety and effectiveness of the Dr Sebi himself did not have medical qualifications Although experts consider it generally safe to follow a plant based diet the same safety does not necessarily apply to highly restrictive diets they may benefit from consulting a healthcare professional Following the Dr. Sebi diet may result in a vitamin B-12 deficiency A person may be able to prevent this by consuming supplements and fortified foods Vitamin B-12 is an essential nutrient necessary for the health of nerve and blood cells and for making DNA In general, people following vegan or vegetarian diets and older adults have a risk of B-12 deficiency. Doctors may recommend that people who do not consume animal products take B-12 supplements or eat foods fortified with B-12 Dietary protein helps support the health of the brain According to current guidelines most females ages 14 and above should consume 46 grams (g) of protein daily while most males of the same age should consume 56 g However, the Dr. Sebi diet restricts other sources of plant protein, such as lentils, soy A person would need to eat an unusually large amount of the permitted protein sources to meet daily requirements Research suggests that it is important to eat a wide variety of plant foods to absorb enough amino acids This may be difficult when following the Dr Omega-3 fatty acids are important components of cell membranes Sebi diet includes plant sources of omega-3s However, the body more readily absorbs these acids from animal sources. A 2019 study indicates that a vegan diet contains little or none of two omega-3 fatty acids Sebi diet may benefit from taking an omega-3 supplement Sebi’s recipes often contain unusual ingredients or his patented botanical supplements a person who is not strictly adhering to the diet could easily adapt some recipes to make healthful The diet’s proponents also recommend expensive products without scientific evidence to support their use the diet may bring some benefits associated with other plant-based diets Eating more whole fruits and vegetables in general could positively affect health It could also help a person to lose weight if that is a goal People can conduct research and speak with a healthcare professional before trying any new diet A healthcare professional can ensure the person gets all essential nutrients such as through supplementation if necessary SEBI notifies amendments to ICDR Regulations On March 3, 2025, the Securities and Exchange Board of India (SEBI) notified the SEBI (Issue of Capital and Disclosure Requirements) (Amendment) Regulations, 2025 The amendments aim to streamline public capital raising and align existing frameworks with corporate practices and investor protection needs The amendment also addresses longstanding inconsistencies flagged in SEBI’s observations on offer documents and integrates recommendations from expert committees The amendments were published in the official gazette and came into effect on publication SEBI’s latest amendment includes promoter lock-in periods that have been aligned with the actual usage of issue proceeds If a majority of fresh issue proceeds are intended for capital expenditure or related debt repayment promoters must now retain their minimum contribution for three years the lock-in period has been extended to one year from the earlier six months where proceeds are linked to capital expenditure SEBI has also revised the timeline for public announcements Following the filing of the draft offer document the issuer must now make a public announcement within two working days the earlier requirement of separate pre-issue and price band advertisements has been merged into a single advertisement to be published at least two working days before the issue opens The draft document must remain open for public comments for 21 days from the date of this announcement The rights issue process has undergone substantial simplification SEBI has eliminated the earlier size threshold of INR 500 million (US$5.87 million) which previously determined the applicability of ICDR norms all rights issues by listed issuers must comply with ICDR regulations This move brings uniformity to the disclosure and compliance obligations across the market The documentation and approval process for rights issues has also been made more efficient Issuers are no longer required to file the draft letter of offer with SEBI the document is to be filed directly with the relevant stock exchanges This step removes a substantial layer of regulatory delay while preserving investor access through stock exchange platforms The need to appoint a merchant banker has also been removed under the revised Regulation 69 Responsibilities such as ensuring regulatory compliance and facilitating allotment are now redistributed among the issuer SEBI has added further obligations to ensure transparency Regulation 71 has been revised to specify the documents that must be submitted to the stock exchange These include the draft letter of offer and promoter identity details (such as Permanent Account Number/PAN or company registration data for corporate promoters) In the case of convertible debt instruments a due diligence certificate from the debenture trustee is also required The final letter of offer must be filed with both SEBI and the exchanges with SEBI responsible for public dissemination Rights issue timelines have also been tightened. According to SEBI Circular Faster Rights Issue (Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2025/31) dated March 11 the entire rights issue process must now be completed within 23 working days from board approval This replaces the earlier flexible schedule and provides greater certainty to investors A notable change is the introduction of Regulation 77B which allows promoters to renounce their rights entitlements in favor of specific named investors These investors must apply before 11:00 A.M and the issuer must notify the stock exchange by 11:30 A.M Issuers can also allocate under-subscribed portions of the issue to such investors provided this intention is clearly disclosed in the letter of offer and advertisements This change offers strategic flexibility while maintaining disclosure safeguards To prevent misuse of the simplified framework SEBI has introduced a safeguard under Regulation 61(d) Issuers whose equity shares are under disciplinary suspension as of the reference date will not be eligible to make rights issues This discourages companies facing regulatory action from using rights issues as a short-term liquidity solution SEBI has focused heavily on improving pre-issue and pre-IPO transparency Revisions to Regulations 54 and 95 now require issuers to report all securities transactions by promoters and promoter groups within 24 hours of occurrence from the date of draft filing until issue closure any pre-IPO placements disclosed in draft documents must be reported to stock exchanges within 24 hours of the transaction the amendments also mandate detailed disclosures of any agreements that impact management control or impose legal obligations on the issuer Issuers must also disclose all criminal proceedings against key management personnel and any regulatory actions taken against them Material civil litigations must now meet SEBI’s objective monetary thresholds harmonized with those under the SEBI Listing Regulations SEBI has enabled voluntary disclosure of proforma financials related to recent acquisitions or divestments even if they fall below the materiality threshold This is intended to provide investors with a fuller picture of financial performance especially for companies undergoing structural change Supporting documentation must be certified by the statutory auditor or a peer-reviewed chartered accountant issuers must now provide expanded information on employee benefit schemes Disclosure of standalone financials for working capital utilization has also been clarified requiring consistency between audited standalone and restated consolidated financials where adjustments have occurred hypothetical financial statements used to show what a company’s financials would look like after a major event such as a merger or acquisition reflect a progressive recalibration of India’s capital markets regulatory framework the amendments seek to balance market efficiency with investor protection these changes necessitate a reassessment of internal controls especially those participating in IPOs and rights issues and new norms around SARs underscore SEBI’s intent to strengthen capital formation while guarding against market abuse Our free webinars are packed full of useful information for doing business in India plus free access to our articles and magazines Subscribe now to receive our weekly India Edition newsletter Not convinced? Click here to see our last week's issue The Securities and Exchange Board of India (SEBI) has significantly reduced the number of empanelled forensic auditors for listed companies downsizing the list from 20 firms in 2022 to just 9 in 2025 according to people familiar with the development is driven by a desire to create a “short and manageable” list populated by firms that have a consistent engagement history and proven performance track record over the past three years this streamlining has seen the exit of industry stalwarts such as Ernst & Young only Deloitte Touche Tohmatsu India retains its spot on the new panel While SEBI has not released an official explanation sources indicate that a firm’s past performance—particularly adherence to audit timelines and the quality of reports—played a pivotal role in the selection The regulator also awarded extra points to firms that delivered on time aligning with SEBI’s goal to enhance accountability and efficiency in financial investigations According to the advertisement issued by SEBI in November 2024 the eligibility norms for inclusion were strict: ALSO READ: Call for Cyber Experts: Join FCRF Academy as Trainers and Course Creators The selection process is believed to have evaluated applicants not just on paper credentials but also on their real-world delivery and regulatory familiarity This appears to have worked in favor of smaller more agile firms with proven regulatory partnerships and timely execution over sheer scale or brand “The pruning of the list is not just about compliance but also about capability and credibility It could also be an indirect commentary on the recent shortcomings of some big names,” said a regulatory expert who declined to be named SEBI has maintained market-aligned compensation levels for assignments ranging between Rs 10-30 lakh per audit depending on the size of the company and the audit’s time span While the fee structure isn’t considered extravagant the prestige and credibility that come with being on SEBI’s panel are considered valuable by auditing firms “Being on SEBI’s panel adds significant credibility especially when pitching for clients in the private sector,” said an auditing consultant “But what’s equally significant is the message SEBI is sending—past performance matters more than pedigree.” concerns have surfaced within the auditing community over what this exclusion means for major players Some experts speculate that the absence of well-established firms like PwC India or perceived conflicts of interest in past assignments FE was unable to independently verify whether these firms had even applied for inclusion in the latest panel leaving open the possibility that some may have opted out voluntarily The revised panel will remain valid for three years and the implications for India’s forensic audit ecosystem could be far-reaching With regulatory scrutiny of corporate governance and financial transparency on the rise the smaller list suggests SEBI intends to work closely and more intensively with a trusted set of firms Stay connected for insightful content that not only keeps you informed but also empowers you to navigate the dynamic world of cyber crime © 2017 The420.in. All rights reserved. | Developed by Brainfox Infotech. there has been much anticipation surrounding SEBI's new regulations on options trading Retail traders and market participants have been eager to understand how these changes will impact the overall trading activity in our country we’ll break down SEBI's latest announcements covering the major updates and their effects on traders Let’s dive deep into SEBI's official circular and explore what this means for the future of options trading in India SEBI's primary goal with these changes is to improve market liquidity and help investors manage their risks better This is particularly crucial as retail participation in index options has surged over the past few years leading to increased speculation and volatility (especially around expiry dates) SEBI is trying to control two things in general: High inflow of retail money into index options2 the market regulator revealed a comprehensive set of new rules that would reshape the options trading environment in India SEBI’s announcement introduced six key changes that will significantly affect options traders Let’s go through each of these changes and what they mean for the market: One of the most impactful changes is the increase in the contract size for index derivatives the contract size for index options ranges from ₹5-10 lakhs [This is calculated by multiplying the current value of NIFTY SEBI has mandated that this range be increased to ₹15-20 lakh This means the lot size for Nifty futures and options (F&O) contracts will be increased to ~60 to meet this new requirement So will the case for the contracts of other popular indices This change significantly increases the entry barrier for both option buyers and sellers if they were previously required to pay ₹625 to enter a contract option sellers will face higher margin requirements—potentially tripling their current margins if an Iron Condor strategy previously required ₹50,000 in margin While this could make the market safer by discouraging reckless speculation it also poses challenges for smaller retail traders who may struggle to meet the new margin requirements exchanges like NSE and BSE offer multiple weekly expiries for index options which has contributed to increased speculation and volatility SEBI has decided that each exchange (NSE and BSE) can only offer weekly derivatives contracts for one of its benchmark indices NSE can only offer weekly expiry for the Nifty 50 index or Bank Nifty BSE will be able to offer weekly expiry for either Sensex or BankEx All other indices will only have monthly expiry This reduction in weekly expiries is expected to lower speculation and bring more stability to the market SEBI is also implementing a new rule that requires brokers to collect the full option premium upfront from buyers some brokers allow traders to use leverage through cover orders which reduces the upfront cost of purchasing options if a trader sets a stop loss at ₹90 for a ₹100 option they may only be required to pay the maximum potential loss instead of the full premium all option premiums must be collected upfront eliminating the possibility of using leverage to reduce upfront costs This change primarily affects traders using brokers that allow leveraged positions Most discount brokers already collect full premiums upfront those using cover orders to reduce entry costs will now need to pay the full premium which could make some strategies less attractive To control the heightened volatility seen on options expiry days SEBI has introduced an additional margin requirement called the "extreme loss margin." This will increase the margin requirements for option sellers by 2% on expiry days if you were previously required to put up ₹10 lakh as margin While this rule may not significantly affect overall market liquidity it aims to reduce the risks associated with large SEBI monitors position limits for index derivatives at the end of each trading day This ensures that no single broker exceeds a certain percentage of the total open interest (OI) in the market The new rule introduces intraday monitoring where brokers' positions will be checked at four random intervals throughout the day This change could be problematic for traders who rely on real-time market movements as it may prevent them from entering trades if their broker exceeds the market-wide position limit the rule won’t be implemented until April 2025 The final rule removes the margin benefit for calendar spreads on expiry days A calendar spread involves holding both long and short positions in contracts of different expiries traders received a margin benefit for these positions on expiry day This rule may discourage traders from using calendar spreads While this change targets a specific group of traders it may reduce the attractiveness of certain trading strategies The implementation of these changes will occur in phases The first two significant changes regarding contract size and weekly expiries are set to take effect on November 20 such as the removal of calendar spread treatment This staggered approach allows brokers and traders time to adjust to the new regulations let’s dive into the potential advantages and disadvantages of SEBI’s new rules: One of the main concerns is that the increased margin requirements could push retail traders towards other speculative instruments like fantasy gaming apps or even crypto trading They may seek out markets with lower entry barriers option buyers may start shifting towards out-of-the-money (OTM) options which are cheaper but carry a lower probability of success This could lead to a rise in speculative behaviour and reduced profitability for retail traders these changes are likely to bring more stability to the market By increasing the contract size and reducing the number of weekly expiries This could lead to more natural price movements and reduce the likelihood of manipulation The equity cash segment may also see increased volumes as traders shift away from options and into equities This could result in a more balanced and liquid market overall the new rules may discourage reckless speculation particularly on live trading platforms and YouTube where high-risk strategies have been increasingly promoted With higher margins and stricter monitoring the market is likely to become less prone to manipulative practices SEBI's new rules represent a significant shift in the Indian options trading landscape While the intention behind these changes is to enhance market stability and protect investors it’s essential to stay informed about these changes and adjust their strategies accordingly we can expect further discussions and debates within the financial community But the long-term effects of these changes will ultimately depend on how traders and brokers adapt Watch the entire explainer video on YouTube: End of Small Option Traders in India? SEBI's New Rules on Indian Stock Market! To read SEBI's circular issued on Oct 1, 2024, click here here! when the IPO closes for subscription and opens for trading there is a gap of at least three trading days there are a lot of grey market trading activities that happen Now Securities and Exchange Board of India (SEBI) wants to do something about it For a better understanding, before we get to the proposal details, we should know the grey market premium. Grey Market Premium (GMP) refers to the price at which shares of an upcoming Initial Public Offering (IPO) are traded unofficially in the grey market before their official listing on the stock exchanges like NSE and BSE over-the-counter market where shares are traded based on demand and supply dynamics without regulatory oversight by authorities like SEBI When a company announces an IPO but these shares are not tradable until the listing day investors and traders speculate on the potential listing price GMP is the difference between the expected listing price and the IPO issue price the expected listing price would be around Rs 150 SEBI plans to introduce a regulated platform ("when listed") for pre-listing trading of IPO shares This new mechanism will allow investors to trade shares in a regulated manner during the three days between IPO allotment and listing This initiative will replace the existing unregulated grey market which currently operates during this period The grey market lacks transparency and exposes investors to significant risks Below are some of the benefits of the new portal: The proposal to permit pre-listing trading in shares aims to curb the prevalence of the grey market an unofficial and unregulated market where shares of companies about to go public are traded By establishing a formal pre-listing trading mechanism SEBI intends to bring transparency and regulatory oversight to this activity but we will have to wait for it to get implemented The non-broking products / services like Mutual Funds are not exchange traded products / services and ICICI Securities Ltd is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge Pay minimum 20% upfront margin of the transaction value to trade in cash market segment Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide NSE circular reference NSE/INSP/45191 dated July 31 2020 and other guidelines issued from time to time in this regard Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month Disclaimer : ICICI Securities attempts to ensure the highest level of integrity correctness and authenticity of the content and data updated on the site we may have not reviewed all of the contents and data present on the site and are not responsible or we take no guarantees whatsoever as to its completeness correctness or accuracy since these details are acquired from third party we will not be liable for any loss or damage that arises from the usage of the content The securities quoted are exemplary and are not recommendatory Such representations are not indicative of future results holds no warranty & is not representative of the delivery service availability or quality of the offer and/or products/services under the offer availability or quality of the offer and / or products / services under the offer must be addressed in writing by the customer directly to respective merchants and ICICI Securities will not entertain any communications in this regard The information mentioned herein above is only for consumption by the client and such material should not be redistributed Email id: complianceofficer@icicisecurities.com Attention Investors : Prevent unauthorized transactions in your account Update your mobile numbers/email IDs with your stock brokers Receive information of your transactions directly from Exchange on your mobile/email at the end of the day... Issued in the interest of Investors (Ref NSE : Circular No.: NSE/INSP/27346 BSE : Notice 20140822-30.) It has been observed that certain fraudsters have been collecting data from various sources of investors who are trading in Exchanges and sending them bulk messages on the pretext of providing investment tips and luring the investors to invest in bogus entities by promising huge profits You are advised not to trade on the basis of SMS tips and to take an informed investment decision based on authentic sources... issued in the interest of investor of investor (RefNSE : circular No.: NSE/COMP/42549 India Tel No: 022 - 6807 7100 Fax: 022 - 6807 7803 For any customer service related queries, assistance or grievances kindly Call us at 1860 123 1122 or Email id: headservicequality@icicidirect.com to Mr. Prabodh Avadhoot ICICIdirect.com is a part of ICICI Securities and offers retail trading and investment services.  Member of National Stock Exchange of India Limited (Member code: 07730) BSE Limited (Member code: 103) & Metropolitan Stock Exchange (Member code: 17680),Multi Commodity Exchange of India Limited (Member code: 56250) SEBI Registration number INZ000183631 Name of Compliance Officer (Broking) : Ms. Mamta Shetty E-mail Address : complianceofficer@icicisecurities.com / Tel No: 022-4070 1000 Investments in securities market are subject to market risks read all the related documents carefully before investing The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon Please note Brokerage would not exceed the SEBI prescribed limit Margin Trading is offered as subject to the provisions of SEBI Circular CIR/MRD/DP/54/2017 dated June 13 2017 and the terms and conditions mentioned in rights and obligations statement issued by I-Sec Account would be open after all procedure relating to IPV and client due diligence is completed Registered office of I-Sec is at ICICI Securities Ltd Composite Corporate Agent License No.CA0113 Insurance is the subject matter of solicitation does not underwrite the risk or act as an insurer The advertisement contains only an indication of the cover offered please read the sales brochure carefully before concluding a sale Responsible Disclosure: In case you discover any security bug or vulnerability on our platform or cyber-attacks on our trading platform please report it to ciso@icicisecurities.com or contact us on 022-40701841 to help us strengthen our cyber security.